Picture: Rene Türk

Change in Solys BioDyne Management

At the beginning of September, Stephan Goldenbaum became the new CEO of Estonian Solis BioDyne OÜ. CEO Priit Karjus stepped down to continue the Supervisory Board.

Goldenbaum has worked in biotech since 2003, beginning with Qiagen. From 2018 until joining Solis BioDyne, he worked on developing sales channels in the large Germany-based biotech company Eppendorf Group. He holds Master’s degrees in biology and business integration

Solis BioDyne is operating in Tartu Science Park. The company was established in 1995 and develops and produce enzymes – stable at room temperature due to a specific genetic modification - Stability TAG.